Inhalant abuse with inhalant-induced mood disorder
ICD-10 F18.14 is a billable code used to indicate a diagnosis of inhalant abuse with inhalant-induced mood disorder.
Inhalant abuse refers to the intentional inhalation of volatile substances to achieve psychoactive effects. This behavior can lead to significant health risks, including neurological damage, respiratory issues, and mood disorders. Inhalant-induced mood disorder is characterized by mood disturbances, such as depression or mania, that arise during or after inhalant use. Symptoms may include irritability, mood swings, and depressive episodes. The diagnosis requires a thorough assessment of the patient's substance use history, the presence of mood symptoms, and the exclusion of other mood disorders. Treatment typically involves a combination of behavioral therapies, counseling, and support groups, focusing on cessation of inhalant use and management of mood symptoms. Given the potential for serious health consequences, early intervention and comprehensive treatment plans are crucial for recovery.
Detailed psychiatric evaluation, including substance use history and mood assessment.
Patients presenting with mood swings, irritability, or depressive symptoms linked to inhalant use.
Ensure clear documentation of the relationship between inhalant use and mood symptoms.
Comprehensive substance use assessment and treatment plan.
Patients seeking help for inhalant abuse and associated mood disorders.
Focus on the patient's motivation for change and readiness for treatment.
Used during initial evaluation of a patient with inhalant abuse.
Complete assessment of substance use history and mood symptoms.
Psychiatric evaluation should include a focus on inhalant use.
Inhalant abuse refers to the intentional inhalation of substances for psychoactive effects, while inhalant-induced mood disorder is a mood disturbance that occurs as a direct result of inhalant use.
